Oblique Therapeutics AB
Records under this name other than the patents Oblique Therapeutics AB holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.
Showing 1 to 4 of 4 · Back to Oblique Therapeutics AB
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,208,384 | Sulfinylpyridines and their use in the treatment of cancer Lapsed on the fee record Ended Dec 28, 2025 · USPTO record | Lapsed on the fee record | Ended Dec 28, 2025 | USPTO record |
| US 11,168,069 | Heterocyclylsulfonyl-substituted pyridines and their use in the treatment of cancer Lapsed on the fee record Ended Nov 9, 2025 · USPTO record | Lapsed on the fee record | Ended Nov 9, 2025 | USPTO record |
| US 11,161,815 | Hydrocarbylsulfonyl-substituted pyridines and their use in the treatment of cancer Lapsed on the fee record Ended Nov 2, 2025 · USPTO record | Lapsed on the fee record | Ended Nov 2, 2025 | USPTO record |
| US 11,028,067 | Heteroarylsulfonyl-substituted pyridines and their use in the treatment of cancer Lapsed on the fee record Ended Jun 8, 2025 · USPTO record | Lapsed on the fee record | Ended Jun 8, 2025 | USPTO record |